Search icon

PHARMANOVA, INC.

Company claim

Is this your business?

Get access!

Company Details

Name: PHARMANOVA, INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 01 Jul 2005 (20 years ago)
Entity Number: 3226340
ZIP code: 14654
County: Monroe
Place of Formation: Delaware
Address: 111, VICTOR HEIGHTS PARKWAY, VICTOR, NY, United States, 14654
Principal Address: 111, VICTOR HEIGHTS PARKWAY, VICTOR, NY, United States, 14564

Chief Executive Officer

Name Role Address
RODNEY BROWN Chief Executive Officer 111, VICTOR HEIGHTS PARKWAY, VICTOR, NY, United States, 14564

DOS Process Agent

Name Role Address
PHARMANOVA, INC. DOS Process Agent 111, VICTOR HEIGHTS PARKWAY, VICTOR, NY, United States, 14654

Form 5500 Series

Employer Identification Number (EIN):
562546184
Plan Year:
2016
Number Of Participants:
2
Sponsors Telephone Number:
Plan Year:
2015
Number Of Participants:
2
Sponsors Telephone Number:
Plan Year:
2014
Number Of Participants:
2
Sponsors Telephone Number:
Plan Year:
2013
Number Of Participants:
3
Sponsors Telephone Number:
Plan Year:
2012
Number Of Participants:
3
Sponsors Telephone Number:

History

Start date End date Type Value
2007-08-03 2013-07-09 Address 75 VICTOR HEIGHTS PARKWAY, SUITE D, VICTOR, NY, 14564, USA (Type of address: Chief Executive Officer)
2007-08-03 2013-07-09 Address 75 VICTOR HEIGHTS PARKWAY, VICTOR, NY, 14564, USA (Type of address: Principal Executive Office)
2007-08-03 2013-07-09 Address 75 VICTOR HEIGHTS PARKWAY, VICTOR, NY, 14654, USA (Type of address: Service of Process)
2005-07-01 2007-08-03 Address 150 LUCIUS GORDON DR STE 206, WEST HENRIETTA, NY, 14586, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
130709006848 2013-07-09 BIENNIAL STATEMENT 2013-07-01
110725002266 2011-07-25 BIENNIAL STATEMENT 2011-07-01
090724002438 2009-07-24 BIENNIAL STATEMENT 2009-07-01
070803002592 2007-08-03 BIENNIAL STATEMENT 2007-07-01
050701000800 2005-07-01 APPLICATION OF AUTHORITY 2005-07-01

Trademarks Section

Serial Number:
77845161
Mark:
PHARMANOVA TECHNOLOGY FOR BETTER MEDICINES
Status:
CANCELLED - SECTION 8
Mark Type:
SERVICE MARK
Application Filing Date:
2009-10-09
Mark Drawing Type:
Illustration: Drawing or design which also includes word(s)/letter(s)/number(s)
Mark Literal Elements:
PHARMANOVA TECHNOLOGY FOR BETTER MEDICINES

Goods And Services

For:
Pharmaceutical drug development services and the clinical re-formulation of known drugs to enhance their properties or to enable additional routes of administration
First Use:
2006-11-01
International Classes:
042 - Primary Class
Class Status:
Sec. 8 – Entire Registration
Serial Number:
77840209
Mark:
PHARMANOVA
Status:
CANCELLED - SECTION 8
Mark Type:
SERVICE MARK
Application Filing Date:
2009-10-02
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
PHARMANOVA

Goods And Services

For:
Pharmaceutical drug development services and the clinical re-formulation of known drugs to enhance their properties or to enable additional routes of administration
First Use:
2006-11-01
International Classes:
042 - Primary Class
Class Status:
Sec. 8 – Entire Registration
Serial Number:
77579355
Mark:
NOVASPERSE
Status:
CANCELLED - SECTION 8
Mark Type:
SERVICE MARK
Application Filing Date:
2008-09-26
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
NOVASPERSE

Goods And Services

For:
Material treatment services, namely, processing and treating pharmaceutical products with various compounds for the purpose of enhancing aqueous solubility and bioavailability for use in human and veterinary medicine, health and nutrition; processing and treatment of chemical substances resulting in...
First Use:
2008-11-11
International Classes:
040 - Primary Class
Class Status:
Sec. 8 – Entire Registration
For:
Pharmaceutical drug development services
First Use:
2008-11-11
International Classes:
042 - Primary Class
Class Status:
Sec. 8 – Entire Registration

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 29 Mar 2025

Sources: New York Secretary of State